Technology – Investor’s Business Daily
Investor’s Business Daily |
Technology
Investor’s Business Daily The approach, called CAR–T therapy, uses bioengineering to retrain a patient’s infection-fighting white blood cells to seek out and destroy cancer cells. Analysts say Kite’s manufacturing process stands out in the CAR–T field for its shorter turnaround … IBD Announces First Annual Biotech Innovator AwardsMarkets Insider |
WCPO |
CAR T-cell therapy couldn’t save Northern Kentucky’s Sophia …
WCPO Before she died, Northern Kentucky’s Sophia Kappen took part in a clinical trial that could dramatically change how doctors treat childhood cancer. Her mother … |